OpenLegislation

Paragraph 9 F1

Energetic materials as follows and mixtures thereof, except where the material is incorporated in a medical product—

(a)

ammonium picrate (CAS 131-74-8);

(b)

black powder;

(c)

hexanitrodiphenylamine (CAS 131-73-7);

(d)

difluoroamine (CAS 10405-27-3);

(e)

nitrostarch (CAS 9056-38-6);

(f)

tetranitronaphthalene;

(g)

trinitroanisole;

(h)

trinitronaphthalene;

(i)

trinitroxylene;

(j)

N-pyrrolidinone; 1-methyl-2-pyrrolidinone (CAS 872-50-4);

(k)

dioctylmaleate (CAS 142-16-5);

(l)

ethylhexylacrylate (CAS 103-11-7);

(m)

triethylaluminium (TEA) (CAS 97-93-8), trimethylaluminium (TMA) (CAS 75-24-1), and other pyrophoric metal alkyls and aryls of lithium, sodium, magnesium, zinc or boron;

(n)

nitroglycerin (or glyceroltrinitrate, trinitroglycerine) (NG) (CAS 55-63-0);

(o)

Ethylenediaminedinitrate (EDDN) (CAS 20829-66-7);

(p)

lead azide (CAS 13424-46-9), normal lead styphnate (CAS 15245-44-0) and basic lead styphnate (CAS 12403-82-6), and primary explosives or priming compositions containing azides or azide complexes;

(q)

diethyldiphenylurea (CAS 85-98-3); dimethyldiphenylurea (CAS 611-92-7); methylethyldiphenyl urea;

(r)

N,N-diphenylurea (unsymmetrical diphenylurea) (CAS 603-54-3);

(s)

methyl-N,N-diphenylurea (methyl unsymmetrical diphenylurea) (CAS 13114-72-2);

(t)

ethyl-N,N-diphenylurea (ethyl unsymmetrical diphenylurea) (CAS 64544-71-4);

(u)

4-Nitrodiphenylamine (4-NDPA)(CAS 836-30-6);

(v)

2,2-dinitropropanol (CAS 918-52-5).

Note: For the purpose of this entry, “medical product” means (1) a pharmaceutical formulation designed for human administration in the treatment of medical conditions, and (2) prepackaged for distribution as a clinical or medical product.

Annotations

Textual amendments

F1

Sch. 2A Pt. 9 inserted (16.12.2022) by The Russia (Sanctions) (EU Exit) (Amendment) (No. 17) Regulations 2022 (S.I. 2022/1331), reg. 1(2)(b), Sch. 1 Pt. 2

Notes on the whole SI

Textual amendments

F1

Regulations extended (British overseas territories) (with modifications) (31.12.2020 immediately after both S.I. 2020/590 and S.I. 2020/951 have come into force) by The Russia (Sanctions) (Overseas Territories) Order 2020 (S.I. 2020/1571), arts. 1(1), 2, Schs. 1, 2 (as amended: (11.3.2021) by S.I. 2021/288, arts. 1(1), 2(2); (14.4.2022) by S.I. 2022/453, arts. 1(1), 3-38; (20.7.2022) by S.I. 2022/843, arts. 1(1), 3; (10.11.2022) by S.I. 2022/1167, arts. 1(1), 3-17; (15.12.2022) by S.I. 2022/1338, arts. 1(1), 3-10; (9.3.2023) by S.I. 2023/291, arts. 1(1), 3-9; (20.7.2023) by S.I. 2023/846, arts. 1(1), 3, 5-22; (30.9.2023) by S.I. 2023/846, arts. 1(2), 4; (14.3.2024) by S.I. 2024/370, arts. 1, 3-13; (3.10.2024) by S.I. 2024/987, arts. 1(1), 3-6; and (11.12.2025) by S.I. 2025/1307, art. 1(1), Sch. 15)

Notes on Schedule 2A

Textual amendments

F1

Sch. 2A inserted (1.3.2022) by The Russia (Sanctions) (EU Exit) (Amendment) (No. 3) Regulations 2022 (S.I. 2022/195), reg. 1(2), Sch. (with reg. 11)